fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Smartwatches may help control diabetes through exercise

Written by | 6 Apr 2025

Wearable mobile health technology could help people with Type 2 Diabetes (T2D) to stick to exercise regimes that help them to keep the condition under control, a new… read more.

‘True food’ research database offers rankings for 50,000 processed foods

Written by | 16 Jan 2025

The database, developed by researchers at Mass General Brigham and made available to the public, sheds light on the availability of processed foods at different grocery stores, highlighting… read more.

GLP-1 RA drugs effectively treat obesity in adults without diabetes

Written by | 7 Jan 2025

A meta- analysis of studies evaluating the efficacy and safety of various glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for treating obesity in adults without diabetes, suggests… read more.

Combined health screening can detect liver damage in diabetic patients

Written by | 2 Jan 2025

New research from Karolinska Institutet in Sweden highlights the potential benefits of screening people with type 2 diabetes for liver damage at the same time as they undergo… read more.

Combined screening can detect liver damage in diabetes patients

Written by | 20 Dec 2024

New research from Karolinska Institutet in Sweden highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening… read more.

Tirzepatide shows powerful diabetes-prevention effect in three-year trial

Written by | 2 Dec 2024

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a… read more.

Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity

Written by | 28 Nov 2024

A new study by researchers at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, in collaboration with researchers at Harvard T.H. Chan School of Public… read more.

Diabetes drug shows promise in protecting kidneys

Written by | 22 Nov 2024

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An… read more.

Long-term efficacy and safety profile of Eylea 8 mg with extended dosing intervals in diabetic macular edema confirmed at three years – Bayer

Written by | 28 Oct 2024

Bayer and its collaboration partner Regeneron presented results from the open-label extension study of the clinical trial PHOTON in patients with diabetic macular edema (DME) at three years,… read more.

FDA clears Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for use by people with type 2 diabetes – Insulet Corporation

Written by | 5 Sep 2024

Insulet Corporation , the global leader in tubeless insulin pump technology with its Omnipod brand of products, announced its groundbreaking Omnipod 5 Automated Insulin Delivery System (Omnipod 5)… read more.

A healthy lifestyle may counteract diabetes-associated brain ageing

Written by | 2 Sep 2024

Type 2 diabetes and prediabetes are associated with accelerated brain ageing, according to a new study from Karolinska Institutet in Sweden published in the journal Diabetes Care. The good news… read more.

Type 2 diabetes increased by almost 20% over a decade

Written by | 25 Aug 2024

Type 2 diabetes increased by almost 20% between 2012 and 2022, according to a new study from the University of Georgia. The researchers found an increase in diabetes among all… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.